Hepatocellular carcinoma (HCC) is characterized by the accumulation of unfolded
proteins in the endoplasmic reticulum (ER), which activates the unfolded protein response (UPR). However, the role of ER stress in
tumor initiation and progression is controversial. To determine the impact of ER stress, we applied
tauroursodeoxycholic acid (
TUDCA), a
bile acid with chaperone properties. The effects of
TUDCA were assessed using a
diethylnitrosamine-induced mouse HCC model in preventive and therapeutic settings. Cell metabolic activity, proliferation and invasion were investigated in vitro.
Tumor progression was assessed in the HepG2 xenograft model. Administration of
TUDCA in the preventive setting reduced
carcinogen-induced elevation of
alanine and
aspartate aminotransferase levels, apoptosis of hepatocytes and
tumor burden.
TUDCA also reduced eukaryotic
initiation factor 2α (eIf2α) phosphorylation,
C/EBP homologous protein expression and
caspase-12 processing. Thus,
TUDCA suppresses
carcinogen-induced pro-apoptotic UPR.
TUDCA alleviated hepatic
inflammation by increasing NF-κB inhibitor IκBα. Furthermore,
TUDCA altered the invasive phenotype and enhanced metabolic activity but not proliferation in HCC cells.
TUDCA administration after
tumor development did not alter orthotopic
tumor or xenograft growth. Taken together,
TUDCA attenuates hepatocarcinogenesis by suppressing
carcinogen-induced ER stress-mediated cell death and
inflammation without stimulating
tumor progression. Therefore, this chemical chaperone could represent a novel chemopreventive agent.